2 recruiting, 1 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow ctDNA testing: new trials by email Literature Review of ctDNA testing trials Research Report on ctDNA testing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) Cemiplimab, cemiplimab plus fianlimab, cemiplimab + REGN7075 - Colo-rectal Cancer | Phase 2 | Recruiting | NSABP Foundation Inc | 79 | 2026-04-17 | 2026-09-03 |
| ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer ctDNA Testing, Blood draw, Surveys - Endometrial Cancer | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 30 | 2025-11-25 | 2026-09-25 |
| Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer ctDNA testing - Metastatic Breast Cancer, Circulating Tumor DNA | Completed | Hunan Cancer Hospital | 223 | 2016-12-01 | 2022-06-22 |
Breast Neoplasms (1) · Colonic Neoplasms (1) · Endometrial Neoplasms (1)
Hunan Cancer Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · NSABP Foundation Inc (1)
United States (2)
Quchang Ouyang, MD (1) · Ying Liu, MD, MPH (1)